Sinopia Biosciences, Inc., a clinical-stage biotechnology company at the forefront of innovative drug discovery, has successfully raised $2.2 million in funding, further strengthening its capabilities in the pursuit of novel therapeutics. This significant funding round will enable Sinopia to advance its proprietary computational drug discovery platform, which integrates high-throughput omics data, advanced machine learning techniques, and network biology principles to uncover transformative therapeutic solutions. Headquartered at JLABS San Diego, Sinopia Biosciences is dedicated to leveraging cutting-edge technology to bridge the gap between computational predictions and clinical advancements. The recent influx of capital will support ongoing research and development efforts aimed at expanding Sinopia鈥檚 pipeline of targeted treatments for various diseases, thereby addressing critical unmet medical needs. With this funding, the company is poised to accelerate its clinical programs, enhance its technology infrastructure, and foster strategic partnerships that will drive innovation in the biopharmaceutical landscape. Sinopia's commitment to harnessing the power of data-driven approaches positions it uniquely in the biotechnology sector, enabling it to make significant contributions to modern medicine. As Sinopia Biosciences embarks on this exciting chapter, the company remains focused on its mission to unlock the potential of precision therapeutics through the convergence of science and technology.
Breaking News: Sinopia Biosciences Secures $2.2 Million in Funding for Innovative Drug Discovery Platform
Recently funded 路 $2.2MBiotechnology
Get the full Sinopia Biosciences company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
